Genital Psoriasis

• CLINICAL_TRIALS trial_result · 2026-04-17
  Clinical Trial Update: A Study to Evaluate Effectiveness and Safety of Deucravacitinib in Participants With Non-Pustular Palmoplantar and Genital Psoriasis [Phase 4]

  A Phase 4 study evaluating deucravacitinib for palmoplantar and genital psoriasis was terminated, with study results posted.

• CLINICAL_TRIALS trial_result · 2026-03-25
  Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Subcutaneous Tildrakizumab in Subjects With Moderate to Severe Genital Psoriasis. [Phase 3]

  Phase 3 clinical trial evaluating the efficacy and safety of subcutaneous tildrakizumab in adults with moderate to severe genital psoriasis;…

• CLINICAL_TRIALS trial_result · 2026-02-24
  Clinical Trial Update: Study to Assess the Safety and Efficacy of Subcutaneously Injected Risankizumab in Adult Participants With Genital or Scalp Psoriasis [Phase 4]

  Phase 4 trial updating safety and efficacy of subcutaneously injected risankizumab in adults with genital or scalp psoriasis; results have b…

• CLINICAL_TRIALS research · 2025-01-31
  Clinical Trial Update: Real-World Study of Xeligekimab for Moderate to Severe Plaque Psoriasis(XP-Real)

  A real-world study of Xeligekimab for moderate to severe plaque psoriasis is planned and not yet recruiting, sponsored by Chongqing Genrix B…

• CLINICAL_TRIALS research · 2025-01-29
  Clinical Trial Update: A Study of Tildrakizumab in the Treatment of Genital Psoriasis (CZATCH-Genital-PsO)

  This entry reports a clinical trial evaluating tildrakizumab for genital psoriasis is currently recruiting. The sponsor listed is Almirall.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2018-03-23
  Clinical Trial Update: A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Genital Psoriasis [Phase 3]

  Phase 3 trial of ixekizumab in moderate-to-severe genital psoriasis has completed; results were posted in 2018.